Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

78 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

NCT03580655

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036

Conditions
Advanced Cancers, Advanced Systemic Mastocytosis, Bronchial Neoplasms, +53 more
Locations
  • Honor Health (GIST, mastocytosis, other solid tumors) Scottsdale, Arizona, United States
  • UCLA Hematology Center (mastocytosis) Los Angeles, California, United States
  • UCLA (glial malignancies only) Los Angeles, California, United States
  • Stanford University Comprehensive Cancer Center (GIST) Palo Alto, California, United States
View all 26 locations
View Trial Details
Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

NCT00492856

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Sutter Cancer Center at Roseville Medical Center Roseville, California, United States
  • Sutter Cancer Center Sacramento, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 210 locations
View Trial Details
Completed

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

NCT00551460

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Sutter Cancer Center at Roseville Medical Center Roseville, California, United States
  • Sutter Cancer Center Sacramento, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
View all 192 locations
View Trial Details
Completed

Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy

NCT01472107

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy
  • Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy
  • Ospedali Riuniti di Bergamo Bergamo, Italy
View all 36 locations
View Trial Details
Completed

Phase III Trial in Acute Promyelocytic Leukemia Patients

NCT00482833

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Universitätsklinik Innsbruck Hämatologie Onkologie Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria
  • Universitätsklinik für Innere Medizin III Salzburg Salzburg, Austria
  • Klinikum Bayreuth GmbH Bayreuth, Germany
View all 110 locations
View Trial Details
Completed

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

NCT01253070

Conditions
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +12 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 43 locations
View Trial Details

Related conditions